Risk to the public, Bulovka, exposed contacts, travellers, health workers and Czech official and supporting sources in one place.
Practical bottom line for the Czech Republic: the ordinary risk to the public is very low. Laboratory testing ruled out Ebola disease and other highly dangerous infections in a woman with fever after her return from Uganda on 2 August. Transfer under controlled conditions and precautionary isolation at Bulovka did not represent a confirmed case or community transmission.
On 19 October, CDC issued a Level 1 travel health notice for Kenya: practise usual precautions and avoid contact with people with symptoms and their body fluids. This is not a travel ban on Kenya. CDC: Kenya.
Distinct situations that are easily confused
| Situation | What we know as of 21 October 2026 | Interpretation |
|---|---|---|
| Woman returning from Uganda, 1–2 August | The woman returned from a trip to Uganda on 29 July and telephoned the infectious-diseases unit at Hradec Králové University Hospital on 1 August because of a fever. She was transferred under controlled conditions to precautionary isolation at Bulovka and samples were sent to the Robert Koch Institute in Berlin. On 2 August, Czech health authorities announced that tests including Ebola were negative; she remained in care for further diagnosis. | The suspected Ebola case was ruled out by laboratory testing. This was not a confirmed case or community transmission, and there was no risk to the public. |
| Bulovka | On 20 May the Czech Republic announced the precautionary admission of a US physician after a risk contact; he flew to the Czech Republic on 21 May. According to Czech public information he was symptom-free, in precautionary isolation and under observation. After the incubation period elapsed he was discharged on 10 June, and the disease did not develop in him. | A person in precautionary isolation after a risk contact, not a confirmed case of Ebola in the Czech Republic. |
| Těchonín | According to iROZHLAS/ČTK, a Czech soldier returned on 22 May from a UN observer mission in the DRC and was precautionarily placed in the Těchonín Centre for Biological Protection. An army spokesperson stated that he did not and does not show symptoms; it is not confirmed that he came into direct contact with an infected person. | Precautionary military isolation after a return from the outbreak area, not a confirmed infection. |
| Berlin / Charité | Another US physician, who was infected while working in the DRC, was treated as a confirmed patient at the Charité in Berlin. On 6 June the Charité stated that symptoms had markedly receded after admission and in the first days of treatment, that no virus had been detected in daily monitoring tests since 30 May, and that the patient had been discharged in good health after isolation was lifted. His wife and four children were high-risk contacts; throughout they remained symptom-free and without evidence of Bundibugyo virus. | This situation must be kept separate from the Czech precautionary isolations. The Berlin patient was symptomatic and confirmed; his family contacts and the precautionarily monitored Czech individuals were symptom-free. |
| Frankfurt / University Hospital | On 10 July, CDC reported confirmed Bundibugyo virus infection in a US citizen working for a humanitarian organisation in the DRC. The German health ministry states that the patient was medically evacuated under controlled conditions to Frankfurt on 13 July and admitted to a special isolation unit. | The infection was acquired in the DRC. This is not transmission in Germany; the German health ministry states there is no risk to the public or other patients. |
| United Kingdom | On 21 July, UKHSA announced the precautionary evacuation of a UK resident working for a humanitarian organisation after a potential health-care-related exposure in the DRC. The person remained asymptomatic and was monitored in isolation at a London hospital. | This is not a confirmed case in the United Kingdom. UKHSA assessed the risk to the public as low. |
| France | WHO's daily table through 20 October lists France as 1 imported confirmed case as of 6 July and records the patient as recovered. | An imported confirmed case in Europe, not community transmission and not a Czech case. For the Czech Republic it is important mainly as a reminder of health-system preparedness and of the need to distinguish importation from community transmission. |
Bulovka and Těchonín
Bulovka
Bulovka University Hospital operates the National Centre for the Isolation and Treatment of Highly Dangerous Infections. The Czech authorities used it in May for precautionary monitoring of a US physician after a risk contact and on 1 August for a woman with fever after returning from Uganda. Transfer under controlled conditions and an isolation regime do not mean the uncontrolled introduction of infection. The US physician did not develop the disease, and Ebola was ruled out in the woman by laboratory testing on 2 August.
Těchonín
The Těchonín Centre for Biological Protection is a specialised military facility for biological protection. According to iROZHLAS/ČTK, a Czech soldier was precautionarily isolated there after returning from a UN mission in the DRC. When communicating about this, it is best to give 22 May 2026 as the date of the event and 2 June 2026 as the date of publication.
For the public: the Czech precautionary isolations are important for preparedness and communication, but on their own they do not change the risk assessment for the general public.
What is the risk for the Czech Republic
For the public
The risk to the public in the Czech Republic remains very low. The Czech Republic is not in the vicinity of the affected states, and Ebola does not spread through the air like influenza or COVID-19. In its 21 September press release, ECDC continues to assess the risk of importation into the EU/EEA as very low; neither the laboratory-negative Czech suspected case nor the controlled medical evacuation to Frankfurt of a patient infected in the DRC changes that assessment.
On 20 October, Nigeria’s health ministry and WHO confirmed one imported case of Bundibugyo virus disease in the Abuja Federal Capital Territory. The patient is in isolation and receiving care; the ministry reported 44 identified contacts. According to WHO, symptoms began on 7 October and she was admitted to hospital on 11 October. Arrival from Uganda does not by itself establish where infection occurred: the source of infection and the full travel and exposure history remain under investigation. Nigeria MoH; WHO AFRO, 20 October.
According to WHO and CDC, Kenya has recorded nine confirmed cases and one death as of 20 October. Subsequent cases are linked to the first imported patient and, according to CDC, were detected among contacts already in quarantine; Kenya’s health ministry continues to report no spread in the wider community. The ministry’s direct statement of 20 October was not accessible at this check, so this summary relies on WHO and CDC. CDC; WHO AFRO.
For travellers
Heightened attention applies to people who in the last 21 days were in the affected areas of the DRC, especially in Ituri, North Kivu, South Kivu, Haut-Uele, Tshopo, Bas-Uele, Sud-Ubangi or Nord-Ubangi, or in Uganda, worked in healthcare in the outbreak zone, attended a funeral, cared for a sick person, or had contact with the bodily fluids of a person with suspected or confirmed Ebola disease. ECDC distinguishes an ordinary return without exposure from low-risk and high-risk exposure; measures should be guided by the specific type of contact, not merely by presence in the country.
Return from an affected area and exposure
On 15 June ECDC recommends, for people without exposure, mainly clear information about symptoms and what to do if problems arise. For low-risk exposure it recommends 21 days of self-monitoring of health status, that is, measuring temperature and watching for symptoms twice a day. For high-risk exposure it recommends active monitoring for 21 days, being reachable by public health services, not travelling abroad and, depending on circumstances, limiting social contacts or clinical work.
ECDC reaffirmed very low risk to the general public on 1 October following the medical evacuation to the Netherlands. ECDC.
The ECDC model described on the page checked on 21 October covers the general population of Ituri and North Kivu. It excludes returning health workers and other professionals, who have greater exposure risk and are also subject to specific control measures and monitoring.
The ECDC model for the period 11–25 June and the follow-up preparedness overview, published on 18 June and updated on 10 July, estimate the risk of importation into the EU/EEA as low; in the overview ECDC expresses it as roughly one importation per 24,000 travellers from the main outbreak area into the EU/EEA, with a wide interval of uncertainty. The imported case in France shows that the risk is not zero, but it does not change the ECDC conclusion that the ordinary risk to the public in the Czech Republic remains very low and that the key factor is the rapid identification of symptomatic people with a relevant travel or exposure history.
WHO's updated temporary recommendations of 24 August advise other states to provide current information to travellers, including advice against travel to areas with community transmission. WHO does not recommend flight suspensions or denial of entry to travellers. This is not a blanket travel ban; Czech advice should be read according to the specific destination and exposure.
On 1 October, the Czech MFA updated its DRC warning and continued to advise against travel and urged Czech citizens to leave promptly. It lists the seven provinces affected at that time and reports that the DRC Ministry of Health replaced the earlier blanket quarantine with individual measures based on exposure in categories A, B and C. This is the Czech MFA’s account of DRC rules, not ECDC categories. Specific travel conditions should be checked in the current advice. MZV ČR.
On 16 June the Ugandan Ministry of Health also announced that travellers leaving Uganda do not need a so-called “Ebola-Free Certificate”; testing should be guided by symptoms, contact with a confirmed case and the assessment of health authorities.
On 10 October, RIVM announced that the patient treated at LUMC in Leiden had recovered, tested negative and left hospital on 9 October after isolation ended. RIVM’s 12 October update continues to assess the likelihood of spread in the Netherlands and Europe as very small. RIVM.
US travel measures need to be read separately: CDC’s situation summary was updated on 20 October, and the returning-travellers page on 11 September. CDC says that travellers, including US citizens, who were in the DRC within 21 days before their flight may not board commercial flights to the United States; US citizens and nationals who were only in Uganda or South Sudan must enter through designated airports for enhanced screening. On 11 October, CDC issued a further order extending restrictions for specified foreign nationals for 30 days. CDC recommends avoiding all travel to Ituri and North Kivu, avoiding nonessential travel to Haut-Uele and Tshopo, and taking enhanced precautions in other parts of the DRC and in Uganda. These are US rules, not Czech or EU measures, and they do not change the ECDC conclusion of very low risk for the general EU/EEA population.
For health workers
Suspected Ebola is rare in the Czech setting, but it requires a procedure rehearsed in advance: telephone triage, travel history, isolation, protective equipment, contact with the public health service and coordination with a specialised infectious-diseases unit.
If in the last 21 days you have returned from an area of the DRC or Uganda with documented Bundibugyo virus cases and you develop a fever, marked weakness, vomiting, diarrhoea or bleeding symptoms, contact a health service by telephone and state your travel history. Do not go to a waiting room without arranging it first.
On 8 October, the Czech MFA updated its Uganda advice: travel to areas bordering the DRC only when strictly necessary and exercise increased caution elsewhere. According to the MFA, the Uganda–DRC border remains closed to ordinary movement, and Ugandan citizens and residents returning from the DRC face mandatory quarantine. The end of Uganda’s outbreak does not remove the risk of reintroduction. Check the requirements before travelling. Czech MFA.
Sources checked for 21 October: WHO rapid risk assessment, version 4, 20 August 2026, WHO full report of the second Emergency Committee meeting, 28 August, ECDC: deployment and risk assessment, 21 September, ECDC outbreak page, updated 20 October and checked 21 October and WHO daily epidemiological update through 20 October.
Further sources for the Czech and travel context: iROZHLAS: transfer under controlled conditions after return from Uganda, 1 August (in Czech), iROZHLAS: Ebola and other highly dangerous infections ruled out, 2 August (in Czech), Health Minister Adam Vojtěch: negative laboratory result (in Czech), Czech public health service: information on the suspected case (in Czech), Czech MoH: precautionary admission of a US citizen (in Czech), ČTK/Seznam Zprávy: discharge from Bulovka (in Czech), iROZHLAS/ČTK: Czech soldier in Těchonín (in Czech), Czech MoD/VZÚ: Department of Biological Protection Těchonín, Charité: discharge of the Berlin patient, US CDC: returning travelers, ECDC: risk classification and contact tracing, Uganda MoH: travellers do not require an Ebola-Free Certificate, SZÚ: Czech overview (in Czech), Bulovka University Hospital: National Centre for the Isolation and Treatment of Highly Dangerous Infections, Czech MFA: Uganda, recommendations checked on 21 October and Czech MFA: Congo (Kinshasa), recommendations checked on 21 October. The complete source inventory is on the Sources and methods page.